Enclear Therapies Inc.

Newburyport, MA

UEI
CZ53WXM52XT5
CAGE
8CPE1
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Small Business Joint Venture
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
65 Parker St #3a, Newburyport, MA 01950, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Enclear Therapies Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Smart CSF delivery system for CNS drug therapy for leptomeningeal disease - project summary / abstract cancer cells that… Grant · R43CA281429 National Cancer Institute $811,149
Targeted cerebral spinal fluid (CSF) drug delivery - enclear precision system - enclear therapies is developing new… Grant · R44NS135792 National Institute of Neurological Disorders and Stroke $11,777,336

Quick answers

What is Enclear Therapies Inc.'s UEI?

Enclear Therapies Inc.'s Unique Entity ID (UEI) in SAM.gov is CZ53WXM52XT5.

What is Enclear Therapies Inc.'s CAGE code?

Enclear Therapies Inc.'s CAGE code is 8CPE1.

What is Enclear Therapies Inc.'s primary NAICS code?

Enclear Therapies Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Enclear Therapies Inc. located?

Enclear Therapies Inc.'s physical address in SAM.gov is 65 Parker St #3a, Newburyport, MA 01950, USA.

Is Enclear Therapies Inc. registered in SAM.gov?

Yes. Enclear Therapies Inc.'s SAM.gov registration is active through December 23, 2026.

What is Enclear Therapies Inc.'s most recent federal award?

Enclear Therapies Inc.'s most recent federal grant award is Smart CSF delivery system for CNS drug therapy for leptomeningeal disease - project summary / abstract cancer cells that… (R43CA281429), from National Cancer Institute, on July 1, 2024.

On GovTribe

See Enclear Therapies Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login